Clinical trials
Phase 1 Myasthenia Gravis trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 2 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 11 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 9 |
| Recruiting | 9 |
| Completed | 2 |
| Withdrawn | 2 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tongji Hospital | 3 |
| Zhejiang University | 3 |
| Daishi Tian | 2 |
| Tianjin Huanhu Hospital | 2 |
| Ting Chang, MD | 2 |
| CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 1 |
| Candid Therapeutics | 1 |
| Changzhou No.2 People's Hospital | 1 |
| Chongbo Zhao | 1 |
| Huashan Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myasthenia Gravis | 24 |
| Multiple Sclerosis | 9 |
| Neuromyelitis Optica | 7 |
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 5 |
| Autoimmune Diseases of the Nervous System | 4 |
| Lupus Erythematosus, Systemic | 3 |
| Myositis | 3 |
| Scleroderma, Systemic | 3 |
| Recurrence | 2 |
| Anemia, Hemolytic, Autoimmune | 1 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.